When the network interpreted complete videos from 42 consecutive patients, it boosted detection rates by as much as 50% over physician-alone reads.

Researchers found that the SGLT2 inhibitor had similar value among patients with and without diabetes, sharing their findings in JAMA Cardiology.

Pylarify is a F 18-labeled, prostate-specific membrane antigen targeted PET agent used to pinpoint suspected metastasis or recurrence of the disease. 

Human providers typically spot as few as 30% of these conditions before birth, but a new machine learning model from UCSF bumped the rate up to 95%. 

The American College of Radiology had urged the Hartford, Connecticut-based company to revise its payment policy to match new USPSTF guidelines.

MITA addressed a 9-page letter to Chiquita Brooks-LaSure, following her recent confirmation as the first Black woman to lead the trillion-dollar agency.

Female physicians with young children reported a “significant” decrease in work-from-home productivity compared to males in the same situation. 

Burning studies and reports onto physical discs cost Yale New Haven Health nearly $550,000 in 2019 alone, one expert explained during the SIIM Annual Meeting.

Upon examining a skin lesion they suspected of being malignant, few dermatologists—only 8%—would hold back from performing a biopsy if an AI tool disagreed, classifying it as benign.

Researchers examined data from nearly 1,200 PCI patients, sharing their findings in JACC: Cardiovascular Interventions.